More jobs, investments to come in NC as Thermo Fisher continues to grow

RESEARCH TRIANGLE PARK – Thermo Fisher Scientific, a global provider of products and services that support the life sciences, continues to expand its presence in North Carolina.

Even as the company expands some of its existing facilities in the state, it now plans to build a 375,000 square foot manufacturing facility in Mebane that will create 150 to 200 jobs in manufacturing, engineering and business operations.

The factory is part of a new co-investment with the US government to produce a nationwide supply of much-needed laboratory pipette tips, which are used in disease research and in high volumes for processing diagnostic tests, including COVID-19 testing. Fisher Scientific signed a $ 192.5 million contract with the US Department of Health and Human Services to establish the site, but the company declined to say how much it will co-invest.

Construction will be fully completed by the third quarter of 2024, with manufacturing starting as early as the third quarter of 2023. The site, located at 6086 West Ten Road in the new Buckhorn Industrial Park, approximately 800 meters south of the I -40/85, also has the potential for future expansion across a variety of high-demand product lines, the company said in a press release.

The Thermo Fisher Scientific pipette. (Thermo Fisher scientific photo)

“The new manufacturing facility will help the United States meet future increases in demand for vital laboratory products while creating more high-quality jobs in North Carolina,” said Mark Stevenson, executive vice president and COO of Thermo Fisher Scientific. “With its strategic geographic location and proximity to a diverse talent base, Mebane is an ideal location for this new facility. “

Thermo Fisher currently employs approximately 4,000 people at seven sites in North Carolina, including a center of excellence for laboratory equipment in Asheville, three life science and chemicals manufacturing sites in Durham, manufacturing sites pharmaceuticals in Greenville and High Point and a distribution center in Raleigh.

“Thermo Fisher continues to expand its presence in North Carolina, strengthening our state’s global reputation as a location of choice for life science companies,” said North Carolina Governor Roy Cooper. “This new investment in Mebane and Orange County proves once again that North Carolina’s biotech industry is thriving in every corner of our state.

Thermo Fisher’s investment in Mebane is part of a larger strategy to develop flexible and redundant production capacity in the United States and key regions of the world. The increase in production from recent site expansions helps meet the continued demand for COVID-19-related consumables, including plastics used to collect samples and transport them to laboratories, as well as for vital equipment used for speed up production and allow flexibility for both COVID and non-COVID vaccines and therapies.

“Thermo Fisher Scientific is a key partner in our life sciences infrastructure,” said Bill Bullock, senior vice president of economic development and statewide operations at the North Carolina Biotechnology Center. “This company illustrates the wide range of opportunities available to North Carolinians in the manufacturing of life sciences, from pharmaceutical production to precision parts used in distribution systems. And every facet contributes to the well-being of our communities and to the improvement of health care around the world.

Laboratory consumables – from sample collection vials for diagnostic test kits to plastics and laboratory materials for vaccine production and biobanks – have been critical to the global effort to fight COVID-19. Since the start of the pandemic, Thermo Fisher has invested more than $ 180 million to expand its production of plastic laboratory consumables and an additional $ 600 million to increase the global bioprocessing capacity of vaccines and drugs.

In addition, the company has opened new sites dedicated to the manufacture of viral transport carriers used in the collection of COVID-19 samples and plasmid DNA used in mRNA-based vaccines. The company’s contracted pharmaceutical manufacturing plant in Greenville, where major expansions and upgrades are underway involving several hundred new jobs, began producing Moderna’s COVID-19 vaccine this year.

“North Carolina offers companies like Thermo Fisher a diverse workforce in the life sciences and world-class universities and community colleges that continue to strengthen this workforce day in and day out,” he said. said Machelle Baker Sanders, secretary of the North Carolina Department of Commerce. “In North Carolina, we understand that in order to attract and help businesses compete in today’s global economy, our state must be number one in terms of talent, and we are firmly committed to achieving this goal. “

Thermo Fisher Scientific, headquartered in Waltham, Massachusetts, has annual sales of approximately $ 35 billion and employs more than 90,000 people worldwide. The company supports life science research by helping clients solve complex analytical challenges, improve patient diagnostics and therapies, or increase the productivity of their laboratories. Its brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

“The presence of a company of this size is greatly appreciated and adds another world-class organization to a significant industrial lineup in our region,” said Mebane Mayor Ed Hooks. “Investing in our economy and employment opportunities for highly skilled employees will undoubtedly have a major impact and provide great opportunities for our citizens. “

Renee Price, Chairman of the Orange County Council of Commissioners, said, “Orange County strives to encourage and support economic development in our county, and we especially welcome businesses that offer jobs in the region. 21st century with good salaries and career opportunities for our residents.

(C) NC Biotechnology Center

Comments are closed.